Deferred Tax Assets, Valuation Allowance of Fortress Biotech, Inc. from 31 Dec 2011 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Fortress Biotech, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2024.
  • Fortress Biotech, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $377,965,000, a 3.2% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Fortress Biotech, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $377,965,000 +$11,590,000 +3.2% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q4 2023 $366,375,000 +$48,416,000 +15% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $317,959,000 +$66,907,000 +27% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q4 2021 $251,052,000 +$47,122,000 +23% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q4 2020 $203,930,000 +$35,707,000 +21% 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q4 2019 $168,223,000 +$36,109,000 +27% 31 Dec 2019 10-K/A 09 Apr 2021 2020 FY
Q4 2018 $132,114,000 +$30,469,000 +30% 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q4 2017 $101,645,000 +$6,958,000 +7.3% 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q4 2016 $94,687,000 +$94,620,270 31 Dec 2016 10-K 16 Mar 2018 2017 FY
Q4 2015 $66,730* -$50,500,270 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q4 2014 $50,567,000 +$9,425,000 +23% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q4 2013 $41,142,000 +$41,115,799 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q4 2012 $26,201* -$16,980,799 31 Dec 2012 10-K 14 Mar 2014 2013 FY
Q4 2011 $17,007,000 31 Dec 2011 10-K 18 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.